This costing outlines the financial implications of expanding the Continuous Glucose Monitoring (CGM) Initiative so that all people with type 1 diabetes (T1D) would be eligible for subsidised CGM. People in this expanded cohort would be required to make a co-payment to access this scheme.

Those who are currently eligible for subsidised CGM devices are:

• children and young people, under 21 years of age, with T1D;
• people with T1D aged 21 years or older who have concessional status; 
• women with T1D who are planning for pregnancy, pregnant or immediately post-pregnancy; and
• children and young people with conditions very similar to T1D, who require insulin.

The expansion of the initiative would have no impact on people currently receiving subsidised CGM devices.

This costing also includes of the costs of expanding eligibility for the Insulin Pump Program (IPP) from 18 to up to 21 years of age.